SEC 13F Intelligence

Verdad Advisers, LP / DSGN

Verdad Advisers, LP’s Design Therapeutics Inc Position

Does Verdad Advisers, LP own Design Therapeutics Inc (DSGN)? Yes92.3K shares worth $982,178 (+1.11% of its 13F portfolio) as of Q1 2026.

Position Value
$982,178
Q1 2026
Shares
92.3K
% of Portfolio
+1.11%
Quarters Held
1
currently held

Position History DSGN

Reported value by quarter
Q1 ’26: $982,178Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202692.3K$982,178+1.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Verdad Advisers, LP’s full portfolio or all institutional holders of DSGN.